{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:34:45Z","timestamp":1787578485726,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Qinghai Key Construction Project of Specialized Departments of Qinghai University Affiliated Hospital","award":["Qinghai Weijianwei [2023]133"],"award-info":[{"award-number":["Qinghai Weijianwei [2023]133"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02212-5","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:06:14Z","timestamp":1781510774000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ALKBH2 promotes the Warburg effect and bladder cancer progression under hypoxic conditions via the PI3K\/AKT pathway"],"prefix":"10.1007","volume":"26","author":[{"given":"Zhangjie","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenxing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiange","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqiong","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangqian","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"2212_CR1","doi-asserted-by":"publisher","first-page":"e40149","DOI":"10.2196\/40149","volume":"9","author":"M Chen","year":"2023","unstructured":"Chen M, Li C, Zhang J, Cui X, Tian W, Liao P, et al. Cancer and Atrial Fibrillation Comorbidities Among 25 Million Citizens in Shanghai, China: Medical Insurance Database Study. JMIR Public Health Surveill. 2023;9:e40149.","journal-title":"JMIR Public Health Surveill"},{"issue":"3","key":"2212_CR2","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.annonc.2022.01.073","volume":"33","author":"AA D\u2019Souza","year":"2022","unstructured":"D\u2019Souza AA, Tulpule V, Zang PD, Quinn DI. Bladder cancer: from a therapeutic wilderness to so many options; a guide to practice in a changing landscape. Ann Oncol. 2022;33(3):242\u20133.","journal-title":"Ann Oncol"},{"issue":"6","key":"2212_CR3","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/j.1464-410X.2005.05419.x","volume":"95","author":"SC Smith","year":"2005","unstructured":"Smith SC, Oxford G, Theodorescu D. The promise of gene-expression analysis in bladder cancer: a clinician\u2019s guide. BJU Int. 2005;95(6):874\u201380.","journal-title":"BJU Int"},{"issue":"6213","key":"2212_CR4","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1136\/bmj.280.6213.540","volume":"280","author":"SM Somerville","year":"1980","unstructured":"Somerville SM, Davies JM, Hendry WF, Williams G. Bladder cancer as a prescribed industrial disease: a guide for clinicians. Br Med J. 1980;280(6213):540\u20132.","journal-title":"Br Med J"},{"key":"2212_CR5","doi-asserted-by":"publisher","first-page":"1591191","DOI":"10.3389\/fimmu.2025.1591191","volume":"16","author":"F Zhang","year":"2025","unstructured":"Zhang F, Li S. Antibody-drug conjugates as game changers in bladder cancer: current progress and future directions. Front Immunol. 2025;16:1591191.","journal-title":"Front Immunol"},{"key":"2212_CR6","doi-asserted-by":"crossref","unstructured":"Duraj T, Garcia-Romero N, Carrion-Navarro J, Madurga R, Mendivil AO, Prat-Acin R et al. Beyond the Warburg Effect: Oxidative and Glycolytic Phenotypes Coexist within the Metabolic Heterogeneity of Glioblastoma. Cells. 2021; 10(2).","DOI":"10.3390\/cells10020202"},{"issue":"15","key":"2212_CR7","doi-asserted-by":"publisher","first-page":"3824","DOI":"10.1016\/j.cell.2024.06.026","volume":"187","author":"SM Fendt","year":"2024","unstructured":"Fendt SM. 100 years of the Warburg effect: A cancer metabolism endeavor. Cell. 2024;187(15):3824\u20138.","journal-title":"Cell"},{"key":"2212_CR8","doi-asserted-by":"crossref","unstructured":"Sabbah A, Delouya G, Laskine M, Taussky D. Metabolic Plasticity in Prostate Cancer: The Warburg Effect and Its Clinical Relevance. Am J Clin Oncol 2025.","DOI":"10.1097\/COC.0000000000001215"},{"issue":"7","key":"2212_CR9","first-page":"809","volume":"50","author":"MJ Duran","year":"2004","unstructured":"Duran MJ, Chosseler M, Pressley T. Regulation of Na,K-pump-mediated transport by prolactin in cultured human prostate epithelial cells. Cell Mol Biol (Noisy-le-grand). 2004;50(7):809\u201314.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"13","key":"2212_CR10","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1158\/0008-5472.CAN-24-1304","volume":"84","author":"JA Enriquez","year":"2024","unstructured":"Enriquez JA, Mittelbrunn M. Warburg Effect Reshapes Tumor Immunogenicity. Cancer Res. 2024;84(13):2043\u20135.","journal-title":"Cancer Res"},{"key":"2212_CR11","doi-asserted-by":"crossref","unstructured":"Mathew M, Nguyen NT, Bhutia YD, Sivaprakasam S, Ganapathy V, Correction et al. Mathew Metabolic Signature of Warburg Effect in Cancer: An Effective and Obligatory Interplay between Nutrient Transporters and Catabolic\/Anabolic Pathways to Promote Tumor Growth. Cancers. 2024, 16, 504. Cancers (Basel) 2024; 16(9).","DOI":"10.3390\/cancers16091627"},{"issue":"4","key":"2212_CR12","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.celrep.2013.07.027","volume":"4","author":"P Li","year":"2013","unstructured":"Li P, Gao S, Wang L, Yu F, Li J, Wang C, et al. ABH2 couples regulation of ribosomal DNA transcription with DNA alkylation repair. Cell Rep. 2013;4(4):817\u201329.","journal-title":"Cell Rep"},{"issue":"14","key":"2212_CR13","doi-asserted-by":"publisher","first-page":"6620","DOI":"10.1093\/nar\/gks327","volume":"40","author":"TJ Meza","year":"2012","unstructured":"Meza TJ, Moen MN, Vagbo CB, Krokan HE, Klungland A, Grini PE, et al. The DNA dioxygenase ALKBH2 protects Arabidopsis thaliana against methylation damage. Nucleic Acids Res. 2012;40(14):6620\u201331.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2212_CR14","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1021\/ac5044187","volume":"87","author":"R Yufa","year":"2015","unstructured":"Yufa R, Krylova SM, Bruce C, Bagg EA, Schofield CJ, Krylov SN. Emulsion PCR significantly improves nonequilibrium capillary electrophoresis of equilibrium mixtures-based aptamer selection: allowing for efficient and rapid selection of aptamer to unmodified ABH2 protein. Anal Chem. 2015;87(2):1411\u20139.","journal-title":"Anal Chem"},{"issue":"3","key":"2212_CR15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1093\/jmcb\/mjt012","volume":"5","author":"A Solberg","year":"2013","unstructured":"Solberg A, Robertson AB, Aronsen JM, Rognmo O, Sjaastad I, Wisloff U, et al. Deletion of mouse Alkbh7 leads to obesity. J Mol Cell Biol. 2013;5(3):194\u2013203.","journal-title":"J Mol Cell Biol"},{"issue":"3","key":"2212_CR16","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1440-1746.2010.06531.x","volume":"26","author":"W Gao","year":"2011","unstructured":"Gao W, Li L, Xu P, Fang J, Xiao S, Chen S. Frequent down-regulation of hABH2 in gastric cancer and its involvement in growth of cancer cells. J Gastroenterol Hepatol. 2011;26(3):577\u201384.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"2212_CR17","doi-asserted-by":"publisher","first-page":"6946","DOI":"10.1038\/s41598-022-10561-w","volume":"12","author":"D Song","year":"2022","unstructured":"Song D, Zhang D, Chen S, Wu J, Hao Q, Zhao L, et al. Identification and validation of prognosis-associated DNA repair gene signatures in colorectal cancer. Sci Rep. 2022;12(1):6946.","journal-title":"Sci Rep"},{"issue":"3","key":"2212_CR18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/aps.2010.216","volume":"32","author":"SS Wu","year":"2011","unstructured":"Wu SS, Xu W, Liu S, Chen B, Wang XL, Wang Y, et al. Down-regulation of ALKBH2 increases cisplatin sensitivity in H1299 lung cancer cells. Acta Pharmacol Sin. 2011;32(3):393\u20138.","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"2212_CR19","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/cas.12089","volume":"104","author":"T Fujii","year":"2013","unstructured":"Fujii T, Shimada K, Anai S, Fujimoto K, Konishi N. ALKBH2, a novel AlkB homologue, contributes to human bladder cancer progression by regulating MUC1 expression. Cancer Sci. 2013;104(3):321\u20137.","journal-title":"Cancer Sci"},{"key":"2212_CR20","doi-asserted-by":"publisher","first-page":"973781","DOI":"10.3389\/fragi.2022.973781","volume":"3","author":"ES Arvanitaki","year":"2022","unstructured":"Arvanitaki ES, Stratigi K, Garinis GA. DNA damage, inflammation and aging: Insights from mice. Front Aging. 2022;3:973781.","journal-title":"Front Aging"},{"key":"2212_CR21","doi-asserted-by":"crossref","unstructured":"Liu Y, Liang G, Xu H, Dong W, Dong Z, Qiu Z et al. Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance. Cell Metab 2021; 33(6).","DOI":"10.1016\/j.cmet.2021.04.001"},{"key":"2212_CR22","doi-asserted-by":"crossref","unstructured":"AlMaazmi FI, Bou Malhab LJ, ElDohaji L, Saber-Ayad M. Deciphering the Controversial Role of TP53 Inducible Glycolysis and Apoptosis Regulator (TIGAR) in Cancer Metabolism as a Potential Therapeutic Strategy. Cells. 2025; 14(8).","DOI":"10.3390\/cells14080598"},{"key":"2212_CR23","doi-asserted-by":"crossref","unstructured":"Karim S, Burzangi AS, Ahmad A, Siddiqui NA, Ibrahim IM, Sharma P et al. PI3K-AKT Pathway Modulation by Thymoquinone Limits Tumor Growth and Glycolytic Metabolism in Colorectal Cancer. Int J Mol Sci 2022; 23(4).","DOI":"10.3390\/ijms23042305"},{"key":"2212_CR24","doi-asserted-by":"publisher","first-page":"103732","DOI":"10.1016\/j.dnarep.2024.103732","volume":"141","author":"UP Shaji","year":"2024","unstructured":"Shaji UP, Tuti N, Alim SK, Mohan M, Das S, Meur G, et al. Inhibition of human DNA alkylation damage repair enzyme ALKBH2 by HIV protease inhibitor ritonavir. DNA Repair (Amst). 2024;141:103732.","journal-title":"DNA Repair (Amst)"},{"issue":"5","key":"2212_CR25","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1021\/acschembio.6b00085","volume":"11","author":"C You","year":"2016","unstructured":"You C, Wang P, Nay SL, Wang J, Dai X, O\u2019Connor TR, et al. Roles of Aag, Alkbh2, and Alkbh3 in the Repair of Carboxymethylated and Ethylated Thymidine Lesions. ACS Chem Biol. 2016;11(5):1332\u20138.","journal-title":"ACS Chem Biol"},{"issue":"1","key":"2212_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","volume":"18","author":"X Jing","year":"2019","unstructured":"Jing X, Yang F, Shao C, Wei K, Xie M, Shen H, et al. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer. 2019;18(1):157.","journal-title":"Mol Cancer"},{"key":"2212_CR27","doi-asserted-by":"publisher","first-page":"104773","DOI":"10.1016\/j.critrevonc.2025.104773","volume":"213","author":"J Yang","year":"2025","unstructured":"Yang J, Chen R. Radiosensitization strategies for hepatocellular carcinoma: Mechanisms, therapeutic advances, and clinical perspectives. Crit Rev Oncol Hematol. 2025;213:104773.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3246","key":"2212_CR28","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1126\/science.125.3246.496.b","volume":"125","author":"P Hochstein","year":"1957","unstructured":"Hochstein P. Glycolysis by tumor mitochondria and the action of insulin. Science. 1957;125(3246):496\u20138.","journal-title":"Science"},{"issue":"34","key":"2212_CR29","doi-asserted-by":"publisher","first-page":"20734","DOI":"10.1074\/jbc.R115.656462","volume":"290","author":"BI Fedeles","year":"2015","unstructured":"Fedeles BI, Singh V, Delaney JC, Li D, Essigmann JM. The AlkB Family of Fe(II)\/\u03b1-Ketoglutarate-dependent Dioxygenases: Repairing Nucleic Acid Alkylation Damage and Beyond. J Biol Chem. 2015;290(34):20734\u201342.","journal-title":"J Biol Chem"},{"key":"2212_CR30","doi-asserted-by":"crossref","unstructured":"Kaur S, Maheswaran P, Kaur S, Lai Y, Salah E, Zhang D et al. Evidence human FTO catalyses hydroxylation of N6-methyladenosine without direct formation of a demethylated product contrasting with ALKBH5\/2\/3 and bacterial AlkB. Nucleic Acids Res 2025; 53(16).","DOI":"10.1093\/nar\/gkaf813"},{"issue":"3","key":"2212_CR31","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.cell.2008.04.013","volume":"133","author":"L Salmena","year":"2008","unstructured":"Salmena L, Carracedo A, Pandolfi PP. Tenets of PTEN tumor suppression. Cell. 2008;133(3):403\u201314.","journal-title":"Cell"},{"key":"2212_CR32","doi-asserted-by":"publisher","first-page":"175909","DOI":"10.1016\/j.ejphar.2023.175909","volume":"955","author":"S Rezaei","year":"2023","unstructured":"Rezaei S, Nikpanjeh N, Rezaee A, Gholami S, Hashemipour R, Biavarz N, et al. PI3K\/Akt signaling in urological cancers: Tumorigenesis function, therapeutic potential, and therapy response regulation. Eur J Pharmacol. 2023;955:175909.","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"2212_CR33","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nrc3037","volume":"11","author":"MC Hollander","year":"2011","unstructured":"Hollander MC, Blumenthal GM, Dennis PA. PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Nat Rev Cancer. 2011;11(4):289\u2013301.","journal-title":"Nat Rev Cancer"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02212-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02212-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02212-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:11:24Z","timestamp":1787577084000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02212-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2212"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02212-5","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"25 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the Ethics Committee of the Affiliated Hospital of Qinghai University (Study identifier P-SL-2023-463).","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all the patients in accordance with the ethical principles of the Declaration of Helsinki.","order":4,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"306"}}